Sanofi finishes buyout of Genzyme

04/10/2011 | Reuters

Sanofi-Aventis finalized a deal worth about $20.1 billion to take over Genzyme. The acquisition, which gives Sanofi access to Genzyme's orphan-drug business, will be partly funded through a $7 billion note offering.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA